Cencora solution
EU Health Technology Assessment (HTA) consulting
As the European Union takes bold strides towards harmonizing and enhancing its healthcare landscape, the implementation of the Joint Clinical Assessment (JCA) stands as a pivotal moment. At Cencora, we help companies at all stages of the EU HTA journey, from early evidence to post-JCA implementation at the national level.
EU HTA Center of Excellence
Our EU HTA Center of Excellence brings together expert domain leaders with deep knowledge of the intricacies of this complex initiative. Unveiling the path forward, our experts offer unparalleled insights into the current status of EU HTA, shed light on the uncertainties that lie ahead, and equip you with solutions to help you navigate this transformative landscape.
500+
HTA submissions delivered across Europe over the last 5 years
250+
HTA, RWE, and market access consultants across Europe
Meet Ruairi O’Donnell, EU HTA Lead at Cencora
A 20-year veteran of the global market access and HEOR consulting services sector, Ruairi has held numerous leadership positions in leading global consulting organizations, with a strong background in value strategy, evidence development, and market access pathways. Prior to taking on his role as EU HTA lead for Cencora, he was Senior Director of Evidence Generation and Value Communications.
One expert partner, from early evidence advice to post-JCA implementation
Cencora helps deliver an optimized JCA by providing specialist capabilities, robust capacity, and strategic partnership.
Readiness
- Affiliate activation and engagement models
- Education and awareness initiatives
- Organisational audit and change management
Strategy
- Joint scientific consultation (JSC)
- Early evidence planning
- PICO simulation
- Core HTA strategy and EU launch planning
Implementation
- Evidence review
Statistical analysis
- JCA submission writing
- Post-JCA implementation support
Contact our EU HTA Center of Excellence
Unveiling the path forward, our experts offer unparalleled insights into the current status of the Joint Clinical Assessment (JCA) and shed light on the uncertainties that lie ahead, and the solutions to help you navigate those.
Contact our team to learn more or to meet with us at an upcoming conference.